Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control studyAnn. Rheum. Dis 2022 Jul 04;[EPub Ahead of Print], L Plaçais, S Dalle, O Dereure, S Trabelsi, S Dalac, D Legoupil, H Montaudié, JP Arnault, J De Quatrebarbes, P Saiag, F Brunet-Possenti, T Lesimple, E Maubec, F Aubin, F Granel-Brocard, JJ Grob, PE Stoebner, C Allayous, B Oriano, C Dutriaux, L Mortier, C Lebbe
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.